Developing orphan drugs, which are intended to treat rare diseases, involves navigating specific regulatory considerations to ensure the safety, efficacy, and accessibility of these treatments for patients with rare conditions. Regulatory agencies worldwide have established frameworks and incentives to encourage the development of orphan drugs and expedite their approval process.
Related Tags:
- Rare Diseases Conferences 2024
- Orphan Drugs Conferences 2024
- Orphan Diseases Conferences
- Rare Diseases and Orphan Drugs summit
